CTI BioPharma Corp. (NASDAQ:CTIC) Receives Average Rating of Buy from Analysts

CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has earned an average rating of “Buy” from the nine research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to the company. The […]

Related Keywords

United States , ,Raymond James Financial Services Advisors Inc ,Geode Capital Management ,Cti Biopharma Corp ,Biopharma Corp ,Nasdaq ,Blair William Co ,Needham Company ,Advisory Alpha ,Biopharma Company Profile Get Rating ,Get Rating ,Capital Acquisition ,Capital Management ,James Financial Services Advisors ,Pharma Company Profile ,Pharma Corp ,Cti Biopharma ,Nasdaq Ctic ,Arctic ,Medical ,Ratings ,Consensus ,